Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT00515411 · COMPLETED
Trial details
- NCT number
- NCT00515411
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-23
- Primary completion
- 2018-10-26
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.